Time course of discriminative stimulus effects of bretazenil and chlordiazepoxide in rats

European Journal of Pharmacology

Volumn 305, Issue 1-3, 1996, Pages 7-12

  Bronson, Maureen ^b   Chen, Hsu Chen ^b  

^a AUBURN UNIVERSITY   (United States)

^b NONE

Author keywords

benzodiazepine; bretazenil; chlordiazepoxide; drug discrimination; rat; time course

Indexed keywords

BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BRETAZENIL; CHLORDIAZEPOXIDE; PARTIAL AGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE TIME EFFECT RELATION; DRUG DISCRIMINATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029889277     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00116-1     Document Type: Article

References (15)

1. Andrews, J.S. and D.N. Stephens, 1990, Drug discrimination models in anxiety and depression, Pharmacol. Ther. 47, 267.
2. Andrews, J.S. and D.N. Stephens, 1991, Discriminative stimulus properties of the benzodiazepine receptor partial agonist β-carbolines abecarnil and ZK95962: a comparison with chlordiazepoxide, Behav. Pharmacol. 2, 171.
3. Ator, N.A., 1990, Drug discrimination and drug stimulus generalization with anxiolytics, Drug Dev. Res. 20, 189.
4. Boxenbaum, H.G., K.A. Geitner, M.L. Jack, W.R. Dixon and S.A. Kaplan, 1977, Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HCl in healthy subjects: multiple-dose oral administration, J. Pharmacokin. Biopharm. 5, 25.
5. Bronson, M.E., M.C. Newland and W.R. Ravis, 1994, Pharmacokinetic-pharmacodynamic modeling of 5′N-ethylcarboxaminoadenosine (NECA) effects on fixed interval responding in rats, Behav. Pharmacol. 5, 106.
6. Haefely, W., J.R. Martin and P. Schoch, 1990, Novel anxiolytics that act as partial agonists at benzodiazepine receptors, Trends Pharmacol. Sci. 11, 452.
7. Jarbe, T.U.C., 1993, Repeated testing within drug discrimination learning: time course studies with cocaine, amphetamine, and 3-PPP, Pharmacol. Biochem. Behav. 44, 481.
8. Mandema, J.W., M.T. Kuck and M. Danhof, 1992, Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship, Br. J. Pharmacol. 105, 164.
9. Sanger, D.J., 1987, Further investigation of the stimulus properties of chlordiazepoxide and zolpidem. Agonism and antagonism by two novel benzodiazepines, Psychopharmacology 93, 365.
10. Sanger, D.J. and B. Zivkovic, 1994, Discriminative stimulus effects of alpidem, a new imidazopyridine anxiolytic, Psychopharmacology 113, 395.
11. Schechter, M.D., 1987, MDMA as a discriminative stimulus: isomeric comparisons, Pharmacol. Biochem. Behav. 27, 41.
12. Silverman, K., G.K. Mumford and R.R. Griffiths, 1994, A procedure for studying the within-session onset of human drug discrimination, J. Exp. Anal. Behav. 61, 181.
13. Stephens, D.N., G.T. Shearman and W. Kehr, 1984, Discriminative stimulus properties of β-carbolines characterized as agonists and inverse agonists at central benzodiazepine receptors, Psychopharmacology 83, 233.
14. Tomie, A., P.L. Shultz, M.S. Spicer and L.L. Peoples, 1995, Drug discrimination training with low doses: maintenance of discriminative control, Pharmacol. Biochem. Behav. 50, 115.
15. Winger, G. and S. Herling, 1982, Discriminative stimulus effects of pentobarbital in rhesus monkeys: tests of stimulus generalization and duration of action, Psychopharmacology 76, 172.